Related Experiment Video

Updated: Jun 18, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Immunomodulatory therapy of cutaneous T-cell lymphoma: a multimodality approach in advanced disease

Jacqueline M Junkins-Hopkins1

  • 1Division of Dermatopathology and Oral Pathology, Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA. jjunkin1@jhmi.edu

Journal of the American Academy of Dermatology
|November 21, 2009
PubMed

Insights

Dialogues in Dermatology offers monthly audio discussions on current dermatologic topics. Expert commentaries summarize key points for Journal of the American Academy of Dermatology readers.

Area of Science:

  • Dermatology
  • Medical Education

Background:

  • The American Academy of Dermatology produces 'Dialogues in Dermatology,' a monthly audio program.
  • This program features discussions among dermatologists on relevant and timely subjects.

Purpose of the Study:

  • To provide readers of the Journal of the American Academy of Dermatology with summaries of key dermatologic topics discussed in the audio program.
  • To enhance accessibility of expert dermatologic insights.

Main Methods:

  • Audio discussions on current dermatologic topics are recorded monthly.
  • Commentaries are provided by the Dialogues Editor-in-Chief, Jacqueline M. Junkins-Hopkins, MD.
  • These commentaries serve as topic summaries following each discussion.

Main Results:

  • Summaries of expert dermatologic discussions are made available.
  • Timely dermatologic topics are presented in an accessible audio format.

Conclusions:

  • The Journal of the American Academy of Dermatology offers a special service by publishing these commentaries.
  • This initiative aims to disseminate current dermatologic knowledge effectively to its readership.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...